Nuformix (LON:NFX) Trading Up 11.1% – What’s Next?

Nuformix plc (LON:NFX) shot up 11.1% during trading on Monday . The stock traded as high as GBX 0.06 ($0.00) and last traded at GBX 0.06 ($0.00). 1,064,872 shares changed hands during trading, a decline of 90% from the average session volume of 10,192,886 shares. The stock had previously closed at GBX 0.05 ($0.00).

Nuformix Stock Performance

The stock’s 50 day moving average price is GBX 0.06 and its two-hundred day moving average price is GBX 0.13. The company has a current ratio of 1.12, a quick ratio of 3.35 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of £475,199.80, a price-to-earnings ratio of -1.63 and a beta of 1.22.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.